Biotech

All Articles

Cullinan, after $25M bargain, restore bispecific to Harbour

.Cullinan Therapy was actually blown away sufficient with Port BioMed's bispecific invulnerable reac...

A deeper consider Intense Biotech's Ferocious 15

.In this full week's episode of "The Best Line," our experts are actually diving in to Strong Biotec...

Lilly deals with stage 2 failing of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's party celebrating the commendation o...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, firings a...

Lykos will ask FDA to rethink its selection observing denial of MDMA therapy for post-traumatic stress disorder

.Adhering to an unsatisfactory presenting for Lykos Therapeutics' MDMA prospect for post-traumatic s...

AN 2 fifty percents headcount, stops phase 3 test after records let down

.AN2 Therapeutics is reassessing its business in reaction to uninspired midphase data, promising to ...

Merck pays $700M for bispecific, spying autoimmune opening and also odds to test Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 million in advance to challenge Amgen in a blood cancer ...

Gilead pays out J&ampJ $320M to leave licensing bargain for seladelpar

.Along With Gilead Sciences almost an FDA choice for its own liver condition drug seladelpar, the pr...

' All hands on deck' at Lilly as peers target weight problems market

.CEO David Ricks may observe the business setting up outdoors tents at basecamp responsible for Eli ...

Entero giving up team, vacating workplace and stopping briefly R&ampD

.Cushion Liquidators has actually transformed Entero Rehabs white as a piece. The financial institut...